SciELO - Scientific Electronic Library Online

 
vol.43 issue1Technical and legal aspects on management of chemical and pharmaceutical residuesDevelopment and validation of an analytical methodology for determination of glycolic acid acid in raw material and dermocosmetic formulations author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Ciências Farmacêuticas

Print version ISSN 1516-9332

Abstract

CARVALHO, Wânia da Silva; MIRANDA, Silvana Spíndola de; PESQUERO, Jorge Luiz  and  GOMES, Maria Aparecida. Diagnostic of rifampicin-resistance of Mycobacterium tuberculosis by polymerase chain reaction. Rev. Bras. Cienc. Farm. [online]. 2007, vol.43, n.1, pp. 31-38. ISSN 1516-9332.  http://dx.doi.org/10.1590/S1516-93322007000100004.

The resistance of Mycobacterium tuberculosis to tuberculostatic drugs has emerged as a major public health threat. The resistance to rifampicin which has been attributed to structural changes in RNA polymerase can be considered as a marker for multi-drug-resistance to tuberculosis (MDR-TB). Patients bearing rifampicin-resistant strains have poor diagnosis even with treatment. Conventional culture-based drug sensibility testing can require several weeks due to the growth. In this paper we describe the most common PCR-based methods for detection of mutations that lead to rifampicin resistance, such as Single-Strand Conformation Polymorphism (SSCP), PCR Heteroduplex and INNO-LIPA. Recently, by Low Stringency using a Single Specific Primer (LSSP) assay, it was standardized a protocol that showed to be rapid and sensitive for the detection of mutations in the rpoB gene.

Keywords : Mycobacterium tuberculosis; Resistance; Rifampicin; PCR.

        · abstract in Portuguese     · text in Portuguese     · pdf in Portuguese